319 related articles for article (PubMed ID: 17785327)
1. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases.
Orbach H; Zandman-Goddard G; Amital H; Barak V; Szekanecz Z; Szucs G; Danko K; Nagy E; Csepany T; Carvalho JF; Doria A; Shoenfeld Y
Ann N Y Acad Sci; 2007 Aug; 1109():385-400. PubMed ID: 17785327
[TBL] [Abstract][Full Text] [Related]
2. Hyperprolactinemia and autoimmune diseases.
Orbach H; Shoenfeld Y
Autoimmun Rev; 2007 Sep; 6(8):537-42. PubMed ID: 17854745
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble Fas levels in patients with autoimmune rheumatic diseases.
Sahin M; Aydintug O; Tunc SE; Tutkak H; Naziroğlu M
Clin Biochem; 2007 Jan; 40(1-2):6-10. PubMed ID: 17056024
[TBL] [Abstract][Full Text] [Related]
4. Altered diurnal rhythm of prolactin in systemic sclerosis.
Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
[TBL] [Abstract][Full Text] [Related]
5. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
[TBL] [Abstract][Full Text] [Related]
6. The importance of vitamin D levels in autoimmune diseases.
Marques CD; Dantas AT; Fragoso TS; Duarte AL
Rev Bras Reumatol; 2010; 50(1):67-80. PubMed ID: 21125142
[TBL] [Abstract][Full Text] [Related]
7. [Neopterin: new immunological marker of autoimmune rheumatic disease].
Nasonov EL; Samsonov MIu; Tilz G; Fuchs D
Klin Med (Mosk); 2000; 78(8):43-6. PubMed ID: 11019525
[TBL] [Abstract][Full Text] [Related]
8. Anti-vitamin D, vitamin D in SLE: preliminary results.
Carvalho JF; Blank M; Kiss E; Tarr T; Amital H; Shoenfeld Y
Ann N Y Acad Sci; 2007 Aug; 1109():550-7. PubMed ID: 17785344
[TBL] [Abstract][Full Text] [Related]
9. [An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs].
Giusti M; Foppiani L; Fazzuoli L; Molinari E; Guido R; Valenti S; Giordano G
Recenti Prog Med; 1999 Mar; 90(3):147-51. PubMed ID: 10228354
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine in rheumatic and autoimmune diseases.
McMurray RW
Semin Arthritis Rheum; 2001 Aug; 31(1):21-32. PubMed ID: 11503136
[TBL] [Abstract][Full Text] [Related]
13. Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases.
Egerer K; Kuckelkorn U; Rudolph PE; Rückert JC; Dörner T; Burmester GR; Kloetzel PM; Feist E
J Rheumatol; 2002 Oct; 29(10):2045-52. PubMed ID: 12375310
[TBL] [Abstract][Full Text] [Related]
14. Large macrophage colony-forming cells identical to high proliferative potential colony-forming cells in peripheral blood of patients with collagen vascular diseases: high occurrence among patients with systemic sclerosis and dermatomyositis.
Horie S; Minota S; Kano S
J Rheumatol; 2000 Oct; 27(10):2378-81. PubMed ID: 11036833
[TBL] [Abstract][Full Text] [Related]
15. A rare case of systemic autoimmune disease with intricate features of systemic sclerosis, lupus, polymyositis and rheumatoid arthritis. Overlap syndrome or mixed connective tissue disease?
Radulescu D; Pripon S; Ciovicescu F; Constantea NA
Acta Reumatol Port; 2007; 32(3):292-7. PubMed ID: 17932479
[TBL] [Abstract][Full Text] [Related]
16. Prolactin and autoimmunity.
Shelly S; Boaz M; Orbach H
Autoimmun Rev; 2012 May; 11(6-7):A465-70. PubMed ID: 22155203
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis.
Zhao J; Zhao Y; He J; Jia R; Li Z
J Rheumatol; 2008 Jun; 35(6):969-74. PubMed ID: 18398945
[TBL] [Abstract][Full Text] [Related]
18. Frequency of abnormal thyroid function tests in Kuwaiti Arabs with autoimmune diseases.
Al-Awadhi AM; Olusi S; Hasan EA; Abdullah A
Med Princ Pract; 2008; 17(1):61-5. PubMed ID: 18059103
[TBL] [Abstract][Full Text] [Related]
19. Serum prolactin level in patients with multiple sclerosis: a case control study.
Harirchian MH; Sahraian MA; Shirani A
Med Sci Monit; 2006 Apr; 12(4):CR177-80. PubMed ID: 16572053
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists.
McCarty MF
Med Hypotheses; 2001 Aug; 57(2):258-75. PubMed ID: 11461185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
